THE WOODLANDS, Texas--Michael Hogan, a professor in the molecular physiology and biophysics department at Baylor College of Medicine, has been appointed chief scientific officer at Genometrix, a developer of microarray devices.
Hogan has served as Genometrix's scientific advisor since its founding in 1993, and is an advisor to the National Institutes of Health in the fields of chemical carcinogens, pharmaceutical design, and DNA technologies. He heads a collaborative project with Genometrix, Baylor College of Medicine, the Univer sity of Texas MD Anderson Cancer Center, and the National Cancer Institute to develop microarray-based systems for cancer research, assessment, and diagnosis.